UMBI-CHOL: Single Port Versus Four Ports Laparoscopic Cholecystectomy and Early Postoperative Pain

Sponsor
Bispebjerg Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT01268748
Collaborator
University Hospital, Gentofte, Copenhagen (Other), University of Copenhagen (Other)
120
3
2
21
40
1.9

Study Details

Study Description

Brief Summary

This is a trial to evaluate if single port laparoscopic cholecystectomy causes less pain than conventional laparoscopic cholecystectomy.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Conventional laparoscopic procedure
  • Procedure: Experimental laparoscopic procedure
N/A

Detailed Description

This study is a randomized, two-arm, double-blinded three-center trial to compare single-port transumbilical laparoscopic cholecystectomy with conventional 4-port laparoscopic cholecystectomy. 120 patients are included with a 1:1 randomization. Three centers participate in the trial.

Inclusion criteria: Female patients, ASA I-III, age between 18 and 75 years, elective laparoscopic cholecystectomy because of biliary pain or recent uncomplicated biliary pancreatitis.

Exclusion criteria: Expected poor compliance, history of cholecystitis or severe pancreatitis, previous open upper abdominal surgery, pregnancy or lactation, preoperative chronic pain or conversion from laparoscopic to open surgery.

Pain and nausea is measured on VAS before the operation and 3 hrs, 1 day, 2 days and 3 days after the operation.

Cosmesis is evaluated after 28 days.

Patients are telephone-interviewed after 12 months and asked about port hernia formation. If hernia is suspected patients are called in for an abdominal ultrasonography.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Efficacy of Transumbilical Versus Standard Laparoscopic Cholecystectomy on Postoperative Pain
Study Start Date :
Sep 1, 2010
Anticipated Primary Completion Date :
Jun 1, 2011
Anticipated Study Completion Date :
Jun 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Other: 4 ports laparoscopic cholecystectomy

Procedure: Conventional laparoscopic procedure
Patients allocated to this group will undergo laparoscopic cholecystectomy using two 12 mm ports and two 5 mm ports
Other Names:
  • Versaport 12 mm
  • Versaport 5 mm
  • Other: One port transumb. laparoscopic surgery

    Procedure: Experimental laparoscopic procedure
    Patients allocated to this group will undergo laparoscopic cholecystectomy using only a transumbilical SILS port
    Other Names:
  • SILS port
  • Outcome Measures

    Primary Outcome Measures

    1. Pain scores on the Visual Analog Scale before surgery [Before surgery]

    2. Pain scores on the Visual Analog Scale 3 hours after surgery [3 hrs after surgery]

    3. Pain scores on the Visual Analog Scale 1 day after surgery [1 day after surgery]

    4. Pain scores on the Visual Analog Scale 2 days after surgery [2 days after surgery]

    5. Pain scores on the Visual Analog Scale 3 days after surgery [3 days after surgery]

    Secondary Outcome Measures

    1. Nausea scores on a 4 point scale before surgery [Before surgery]

      The 4 point scale: none, light, moderate, and severe

    2. Nausea scores on a 4 point scale 3 hours after surgery [3 hours after surgery]

      The 4 point scale: none, light, moderate, and severe

    3. Nausea scores on a 4 point scale 1 day surgery [1 day after surgery]

      The 4 point scale: none, light, moderate, and severe

    4. Nausea scores on a 4 point scale 2 days after surgery [2 days after surgery]

      The 4 point scale: none, light, moderate, and severe

    5. Nausea scores on a 4 point scale 3 days after surgery [3 days after surgery]

      The 4 point scale: none, light, moderate, and severe

    6. Well being scores on the Visual Analog Scale before surgery [Before surgery]

    7. Well being scores on the Visual Analog Scale 3 hours after surgery [3 hours after surgery]

    8. Well being scores on the Visual Analog Scale 1 day after surgery [1 day after surgery]

    9. Well being scores on the Visual Analog Scale 2 days after surgery [2 days after surgery]

    10. Well being scores on the Visual Analog Scale 3 days after surgery [3 days after surgery]

    11. Number of participants with adverse events as a measure of safety and tolerability [Within 30 days after surgery]

      Adverse events include all complications related to surgery

    12. Patient-assessed cosmesis on the Visual Analog Scale 30 days after surgery [30 days after surgery]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 75 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • ASA I-III

    • Planned elective laparoscopic cholecystectomy because of biliary pain or uncomplicated biliary pancreatitis

    Exclusion Criteria:
    • Expected poor compliance

    • History of cholecystitis or severe pancreatitis

    • Earlier open upper abdominal surgery, pregnancy or lactation, chronic pain or conversion to open surgery

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Dept. of Surgery K, Bispebjerg Hospital Copenhagen NV Denmark DK-2400
    2 Gentofte Hospital, University of Copenhagen Gentofte Denmark DK-2920
    3 Dept. of Surgery, Koege Hospital, University of Copenhagen Koege Denmark DK-4600

    Sponsors and Collaborators

    • Bispebjerg Hospital
    • University Hospital, Gentofte, Copenhagen
    • University of Copenhagen

    Investigators

    • Principal Investigator: Haytham Al-Tayar, MD, Dept. of Surgery, Bispebjerg Hospital, University of Copenhagen
    • Principal Investigator: Sami Assaadzadeh, MD, Dept. of Surgery, Gentofte Hospital, University of Copenhagen
    • Principal Investigator: Jacob Rosenberg, MD, DrMSc, Dept. of Surgery, Herlev Hospital, University of Copenhagen
    • Principal Investigator: Flemming Hjørne, MD, Dept. of Surgery, Køge Hospital, University of Copenhagen
    • Principal Investigator: Thue Bisgaard, MD, DrMSc, Dept. of Surgery, Køge Hospital, University of Copenhagen

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01268748
    Other Study ID Numbers:
    • H-3-2010-064
    First Posted:
    Dec 31, 2010
    Last Update Posted:
    Dec 31, 2010
    Last Verified:
    Sep 1, 2010

    Study Results

    No Results Posted as of Dec 31, 2010